News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
682,990 Results
Type
Article (38959)
Company Profile (276)
Press Release (643755)
Section
Business (203817)
Career Advice (1985)
Deals (35356)
Drug Delivery (84)
Drug Development (80765)
Employer Resources (168)
FDA (16084)
Job Trends (14796)
News (344455)
Policy (32429)
Tag
Academia (2530)
Alliances (49035)
Alzheimer's disease (1212)
Approvals (16002)
Artificial intelligence (114)
Bankruptcy (352)
Best Places to Work (11458)
Biotechnology (196)
Breast cancer (101)
Cancer (886)
Cardiovascular disease (76)
Career advice (1656)
Cell therapy (193)
Clinical research (63887)
Collaboration (317)
Compensation (158)
COVID-19 (2520)
Cystic fibrosis (78)
Data (829)
Diabetes (128)
Diagnostics (6090)
Earnings (84091)
Employer resources (146)
Events (108757)
Executive appointments (239)
FDA (16514)
Funding (286)
Gene therapy (146)
GLP-1 (554)
Government (4316)
Healthcare (18649)
Infectious disease (2593)
Inflammatory bowel disease (101)
Interviews (308)
IPO (16263)
Job creations (3622)
Job search strategy (1415)
Layoffs (407)
Legal (7847)
Lung cancer (154)
Manufacturing (148)
Medical device (13140)
Medtech (13145)
Mergers & acquisitions (19100)
Metabolic disorders (348)
Neuroscience (1450)
NextGen Class of 2024 (6493)
Non-profit (4462)
Northern California (1177)
Obesity (209)
Opinion (175)
Patents (94)
People (56104)
Phase I (19814)
Phase II (28128)
Phase III (21007)
Pipeline (202)
Postmarket research (2553)
Preclinical (8422)
Radiopharmaceuticals (234)
Rare diseases (178)
Real estate (5888)
Regulatory (21425)
Research institute (2307)
Resumes & cover letters (349)
Southern California (1062)
Startups (3560)
United States (11422)
Vaccines (533)
Weight loss (156)
Date
Last 7 days (773)
Last 30 days (2634)
Last 365 days (35546)
2024 (30096)
2023 (40074)
2022 (51173)
2021 (55712)
2020 (54087)
2019 (46541)
2018 (35019)
2017 (32110)
2016 (31480)
2015 (37552)
2014 (31318)
2013 (26345)
2012 (28570)
2011 (29263)
2010 (27328)
Location
Africa (713)
Arizona (186)
Asia (36999)
Australia (6034)
California (2665)
Canada (1163)
China (207)
Colorado (115)
Connecticut (117)
Europe (79193)
Florida (385)
Georgia (98)
Illinois (306)
Indiana (175)
Kansas (95)
Maryland (507)
Massachusetts (2165)
Michigan (142)
Minnesota (246)
New Jersey (805)
New York (824)
North Carolina (656)
Northern California (1177)
Ohio (123)
Pennsylvania (737)
South America (1091)
Southern California (1062)
Texas (372)
Utah (77)
Washington State (315)
682,990 Results for "exagen inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
Exagen Inc. Announces Changes to the Board of Directors
Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, today announced changes to the Board of Directors.
April 26, 2024
·
4 min read
Business
Exagen Inc. Reports Strong First Quarter 2024 Results: Raises Guidance for Full Year
Exagen Inc., a leading provider of autoimmune testing solutions, reported financial results for the quarter ended March 31, 2024.
May 13, 2024
·
10 min read
Business
Exagen Inc. to Participate in the 2024 Cantor Global Healthcare Conference
September 4, 2024
·
1 min read
Business
Exagen Inc. Reports Strong Fourth Quarter and Full-Year 2023 Results
Exagen Inc. today reported financial results for the fourth quarter and full year ended December 31, 2023.
March 18, 2024
·
11 min read
Press Releases
Exagen to Announce Third Quarter 2024 Results on November 12, 2024
October 29, 2024
·
1 min read
Biotech Beach
Exagen Inc. to Participate in the KeyBanc Capital Markets Life Sciences & MedTech Investor Forum
Exagen Inc. today announced its participation in the KeyBanc Capital Markets Life Sciences & MedTech Investor Forum, which takes place virtually March 19-20, 2024.
March 8, 2024
·
1 min read
Business
Exagen to Announce First Quarter 2024 Results on May 13, 2024
Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing, will release financial results for the quarter ended March 31, 2024, before the market opens on Monday, May 13, 2024.
April 30, 2024
·
1 min read
Press Releases
Exagen Announces Acceptance of Five Abstracts at 2024 American College of Rheumatology Convergence
October 22, 2024
·
6 min read
Press Releases
Exagen Inc. to Participate in the Canaccord Genuity 44th Annual Growth Conference
August 2, 2024
·
1 min read
Press Releases
Exagen Inc. Reports Strong Second Quarter 2024 Results: Raises Guidance due to Record Performance
August 5, 2024
·
10 min read
1 of 68,299
Next